deltatrials
Completed NA INTERVENTIONAL 2-arm NCT03227367

Osteoclast Impairment in Chronic Periodontitis by Regenerative Materials.

Platelet Rich Fibrin/Biphasic Calcium Phosphate Impairs Osteoclasts Differentiation and Promotes Apoptosis by the Intrinsic Mitochondrial Pathway in Chronic Periodontitis

Sponsor: Meenakshi Ammal Dental College and Hospital

Interventions other : PRF
Updated 5 times since 2017 Last updated: Jul 24, 2017 Started: Mar 17, 2014 Primary completion: Apr 13, 2016 Completion: Mar 18, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Osteoclastic Bone Loss and Periodontal Bone Loss and is currently completed. Meenakshi Ammal Dental College and Hospital leads this study, which shows 5 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Aug 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Meenakshi Ammal Dental College and Hospital
Data source: Meenakshi Ammal Dental College and Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.